Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer

NCT04905316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

NCT04609566

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 90 locations
View Trial Details
Completed

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

NCT04205812

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Reading Hospital and Medical Center Reading, Pennsylvania, United States
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
View all 140 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

NCT04924101

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0102) Gilbert, Arizona, United States
  • University of Colorado Anschutz Medical Campus ( Site 0104) Aurora, Colorado, United States
  • Georgia Cancer Specialists ( Site 0106) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0130) Fort Wayne, Indiana, United States
View all 49 locations
View Trial Details
Completed

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

NCT02576431

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +43 more
Locations
  • Stanford Cancer Center Palo Alto Palo Alto, California, United States
  • UCLA Health Santa Monica Cancer Care Santa Monica, California, United States
  • Memorial Cancer Institute at West Pembroke Pines, Florida, United States
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
View all 98 locations
View Trial Details
Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer

NCT03801304

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CH Aix en Provence Aix-en-Provence, France
  • CHRU de Brest - Hôpital Morvan Brest, France
  • CLCC Caen Caen, France
  • CH de Créteil Créteil, France
View all 13 locations
View Trial Details

Related conditions